SUNDAY, Dec. 2, 2018 -- A marijuana-derived drug that helps control epileptic seizures appears to become less effective over time in some patients, a new Israeli study reports.
Cannabidiol (CBD) liquid has been proven effective against seizures, but about one-third of patients develop tolerance that blunts the drug's effectiveness, according to research presented Sunday at the American Epilepsy Society's annual meeting, in New Orleans.
FRIDAY, Nov. 9, 2018 -- The antidepressant fluoxetine (Prozac) is ineffective in treating a rare, polio-like disorder that can cause muscle weakness and paralysis in children, researchers are reporting.
In the United States, there have been 219 possible cases of acute flaccid myelitis (AFM) reported so far this year, and 80 have been confirmed, according to the U.S. Centers for Disease Control and Prevention.
THURSDAY, Nov.1, 2018 -- The first Food and Drug Administration-approved drug containing an ingredient derived from the marijuana plant went on sale Thursday in the United States.
Epidiolex is a twice-daily oral solution -- a cannabidiol, or CBD liquid -- made by Britain-based GW Pharmaceuticals. It is approved for use in patients 2 years old and older with two types of epileptic syndromes, Dravet syndrome and Lennox-Gastaut syndrome.